{"symbol": "REGN", "companyName": "Regeneron Pharmaceuticals, Inc.", "exchange": "NASDAQ", "industry": "Pharmaceutical Preparation Manufacturing ", "website": "www.regeneron.com", "description": "Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.", "CEO": "Leonard Schleifer", "securityName": "Regeneron Pharmaceuticals, Inc.", "issueType": "cs", "sector": "Manufacturing", "primarySicCode": 2834, "employees": 8100, "tags": ["Health Technology", "Biotechnology", "Manufacturing", "Pharmaceutical Preparation Manufacturing "], "address": "777 Old Saw Mill River Rd", "address2": null, "state": "New York", "city": "Tarrytown", "zip": "10591-6717", "country": "United States", "phone": "19148477000"}